Andrew J. Andrews, PhD

Andrew J. Andrews, PhD

Associate Professor

Research Program

A proposed model for protein-protein interactions in histone acetylation.
Figure 2


Education and Training

Educational Background

  • PhD, Biological Chemistry, University of Michigan, Ann Arbor, MI, 2006
  • BS/MS Microbiology, NCSU, Raleigh, NC, 2000
Research Profile

Research Program

Research Interests

  • Histone chaperone mediated acetylation (Rtt109-Vps75)
  • Specificity and selectivity of p300 and CBP KATs
  • How acetyl-CoA concentration can alter selectivity of histone acetylation
  • How chromatin dynamics influence histone acetylation

Lab Overview

DNA is highly compacted to fit into cells. The initial compaction forms the nucleosome, with each nucleosome consisting of two copies of four histone proteins H2A, H2B, H3 and H4. A major mechanism regulating the accessibility of DNA for the purposes of transcription, replication, DNA recombination, and DNA repair is through post-translational modification (PTM, or chemical modification) of histones. The most common PTMs are acetylation and methylation, with multiple residues targeted on each of the histones. Specific PTMs and their location are associated with either activated or repressed states of chromatin. Changes in histone acetylation correlate with changes in disease. The importance of maintaining proper histone post-translational modifications is made clear by the numerous diseases that correlate with misregulation of these modifications: cancer, heart disease, fetal alcohol syndrome, and Alzheimer’s, to name a few. Specifically, these diseases have each been shown to lack adequate levels of histone acetylation at specific locations. In order to maintain the proper level of acetylation in a healthy cell, lysine acetyltransferases (KATs) are responsible for targeting specific lysines in the histone. Despite the importance of this biological activity, relatively little is known about the factors that influence the location and extent of these post-translational modifications. Understanding how histone acetylation is regulated and, importantly, how it can be manipulated by the environment or through the use of pharmacological agents would allow us to tailor treatments to reverse or even prevent those diseases associated with loss of specific histone acetylation.

Lab Staff

Joy M. Cote, PhD

Postdoctoral Associate

Room: P3117

Daniel D. Krzizike, PhD

Postdoctoral Associate

Room: P3117

Ryan A. Henry, PhD

Visiting Scientist / Past Lab Member

Darlene Curran

Administrative Assistant

Room: P3048

Selected Publications

Cote J.M., Kuo Y.M., Henry R.A., Scherman H., Krzizike D.D., Andrews A.J., Two factor authentication: Asf1 mediates crosstalk between h3 k14 and k56 acetylation. Nucleic Acids Res. 47(14): 7380-7391, 2019. PMC6698667. 11.147

Sidoli S., Kori Y., Lopes M., Yuan Z.F., Kim H.J., Kulej K., Janssen K.A., Agosto L.M., Cunha J.P.C., Andrews A.J., Garcia B.A., One  minute analysis of 200 histone posttranslational modifications by direct injection mass spectrometry. Genome Res. 29(6): 978-987, 2019. PMC6581051. 9.944

Gordon R.E., Zhang L., Peri S., Kuo Y.M., Du F., Egleston B.L., Ng J.M.Y., Andrews A.J., Astsaturov I., Curran T.,Yang Z.J., Statins synergize with hedgehog pathway inhibitors for treatment of medulloblastoma. Clin Cancer Res. 24(6): 1375-1388, 2018. PMC5856627. 8.911

Lee HO, Wang L, Kuo YM, Andrews AJ, Gupta S, Kruger WD. S-adenosylhomocysteine hydrolase over-expression does not alter S-adenosylmethionine or S-adenosylhomocysteine levels in CBS deficient mice. Molecular Genetics and Metabolism Reports, 15:15-21, 2018.

Anthony S.A., Burrell A.L., Johnson M.C., Duong-Ly K.C., Kuo Y.M., Simonet J.C., Michener P., Andrews A., Kollman J.M.,Peterson J.R., Reconstituted impdh polymers accommodate both catalytically active and inactive conformations. Mol Biol Cell. 28(20): 2600-8, 2017. PMC5620369. 14.797

Stepanova D.S., Semenova G., Kuo Y.M., Andrews A.J., Ammoun S., Hanemann C.O., Chernoff J., An essential role for the tumor suppressor merlin in regulating fatty acid synthesis. Cancer Res. 77(18): 5026-5038, 2017. PMC5600854. 8.378

Kuo, Y.M., Henry, R.A., Huang, L., Chen, X., Stargell, L.A., Andrews, A.J. Utilizing targeted mass spectrometry to demonstrate Asf1-dependent increases in residue specificity for Rtt109-Vps75 mediated histone acetylation. PLoS One 10(3), 2015    PubMed

Henry, R.A., Kuo, Y.M., Bhattacharjee, V., Yen, T.J., Andrews, A.J.  Changing the selectivity of p300 by acetyl-CoA modulation of histone acetylation.  ACS Chem. Biol.  10(1): 146-156, 2015 PubMed

Kuo, Y.M., Henry, R.A., Andrews, A.J.  A quantitative multiplexed mass spectrometry assay for studying the kinetic of residue-specific histone acetylation.  Methods.  70(2-3), 127-133, 2014. PubMed

Haery, L., Lugo-Picó, J.G., Henry, R.A., Andrews, A.J., Gilmore, T.D.  Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth.  Mol. Cancer 13:29, 2014. PMC3930761  PubMed

Kuo, Y.M., Andrews, A.J.  Correction: Quantitating the specificity and selectivity of Gcn5-mediated acetylation of histone H3.  PLoS One. 8(10), 2013. PMC3806868  PubMed

Henry, R.A., Kuo, Y.M., Andrews, A.J.  Differences in specificity and selectivity between CBP and p300 acetylation of histone H3 and H3/H4.  Biochemistry 52(34):5746-59, 2013. PMC3756530  PubMed

Kuo, Y.M., Andrews, A.J.  Quantitating the specificity and selectivity of Gcn5-mediated acetylation of histone H3.  PLoS One 8:e54896, 2013.  PMC3578832  PubMed

Andrews, A.J., Luger, K.  Nucleosome structure(s) and stability: Variations on a theme.  Annu. Rev. Biophys. 40:99-117, 2011. Review  PubMed

Böhm, V., Hieb, A.R., Andrews, A.J., Gansen, A., Rocker, A., Tóth, K., Luger, K., Langowski, J.  Nucleosome accessibility governed by the dimer/tetramer interface.  Nucleic Acids Res. 39(8):3093-3102, 2011. PMC3082900  PubMed

Andrews, A.J., Chen, X., Zevin, A., Stargell, L.A., Luger, K.  The histone chaperone Nap1 promotes nucleosome assembly by eliminating nonnucleosomal histone DNA interactions.  Mol. Cell 37:834-842, 2010.  PMC2880918  PubMed

Koutmou, K.S., Casiano-Negroni, A., Getz, M.M., Pazicni, S., Andrews, A.J., Penner-Hahn, J.E., Al-Hashimi, H.M., Fierke, C.A.  NMR and XAS reveal an inner-sphere metal binding site in the P4 helix of the metallo-ribozyme ribonuclease P.  Proc. Natl. Acad. Sci. USA 107:2479-2484, 2010.  PMC2823894   PubMed

Geiss, B.J., Thompson, A.A., Andrews, A., Sons, R.L., Gari, H.H., Keenan, S.M., Peersen, O.B.  Analysis of flavivirus NS5 methyltransferase cap binding.  J. Mol. Biol. 385(5):1643-1654, 2009.  PMC2680092  PubMed

Andrews, A., Downing, G., Brown, K., Park Y., Luger, K.  A thermodynamic model for Nap1-histone interactions.  J. Biol. Chem. 283(47):32412-32418, 2008. PMC2583301   PubMed

Additional Publications


This Fox Chase professor participates in the Undergraduate Summer Research Fellowship
Learn more about Research Volunteering.

Connect with Fox Chase